IONS vs VATE · rev $514.0M vs rev $786.4M
Ionis Pharmaceuticals Inc (IONS) versus Innovate Corp (VATE) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Innovate Corp (VATE) is a engineering & construction company listed on NYSE.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported VATE revenue for 2026-06-30 was $786.4M. Net income was -$6.1M. VATE currently screens at market cap $226.3M.
IONS currently screens at market cap $12.28B. VATE currently screens at market cap $226.3M.
Not investment advice. Open the IONS and VATE stock pages for the full models.
Not investment advice.